Cross-institutional, multifaceted, integrated translational research on hepatocellular carcinoma to develop prevention and treatment strategies, including meta-analyses, cost-effectiveness evaluations, and assessments of healthcare inequities
Funding Agency
Ministry of Health and Welfare
Principal Investigator
Chun-Ying Wu
Project Period
2026/01/01～2029/12/31
National Science and Technology Council
Project Title
Predicting Prognosis of MASLD-related HCC Treatment: Building an Automated System Integrating Clinical Data, Imaging, and Environmental Factors
Funding Agency
National Science and Technology Council
Principal Investigator
Chun-Ying Wu
Project Period
2024/08/01～2027/07/31
Project Title
Risk Assessment of Hepatocellular Carcinoma Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease and Interactions among the Immune System, Microbiome, and Metabolome: Big Data Research, Clinical Studies, Animal Experiments, and Multi-Omics Analyses — Developing Risk Stratification Using Health Big Data and Multimodal Models to Predict Hepatocellular Carcinoma Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease
Funding Agency
National Science and Technology Council
Principal Investigator
Chun-Ying Wu
Project Period
2025/08/01～2028/07/31
Project Title
Investigating the Interplay between Diabetes and Inflammatory Skin Diseases
Funding Agency
National Science and Technology Council
Principal Investigator
Chen-Yi Wu
Project Period
2025/08/01～2028/07/31
Industry-Academia Collaboration
Project Title
[Handa Biopharmaceutical Co., Ltd.] Evaluating the Efficacy and Safety of Dasatinib in the Treatment of Chronic Phase Chronic Myeloid Leukemia Patients: A Real-World Study Conducted in Taiwan
